glp 1 levels in obesity GLP-1 physiology informs the pharmacotherapy of Glucagon-Like Peptide-1: New Regulator in

It reacts not only with oxidized Trx but also with lipid hydroperoxides and H 2 O 2 [37]

eating outpaces physical activity) the human body will not readily convert excess carbohydrates into fat stores but will use them for energy

FIGURE 1 Nanotechnology plays a crucial role in such smart drug delivery by enabling the synthesis of ideal drug carriers ( Graphene-based nanomaterials for drug delivery Graphene is a two-dimensional (2D) carbon allotrope with a hexagonal honeycomb crystal structure (Yu et al., 2020

The problem surfaced in clinical trials run in 1992 by Mojsov and David Nathan, a physician and expert in type 2 diabetes at MGH, and those of Holst and Nauck (Molteni, Chen)

Cardiovasc Toxicol 19(6):4939